Reply to M.C. Chamberlain

Affiliations

¹ Cadence Brain Tumor Center, Northwestern Medicine Chicago Proton Center, Warrenville, IL vgondi@chicagocancer.org.
² Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University, Bronx, NY.
³ University of Maryland School of Medicine, Baltimore, MD.

Comment

Vinai Gondi et al. J Clin Oncol. 2015.

. 2015 Jun 10;33(17):1986.

doi: 10.1200/JCO.2015.60.9297. Epub 2015 Apr 20.

¹ Cadence Brain Tumor Center, Northwestern Medicine Chicago Proton Center, Warrenville, IL vgondi@chicagocancer.org.
² Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University, Bronx, NY.
³ University of Maryland School of Medicine, Baltimore, MD.

No abstract available

Comment on

Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.
Gondi V, Pugh SL, Tome WA, Caine C, Corn B, Kanner A, Rowley H, Kundapur V, DeNittis A, Greenspoon JN, Konski AA, Bauman GS, Shah S, Shi W, Wendland M, Kachnic L, Mehta MP. Gondi V, et al. J Clin Oncol. 2014 Dec 1;32(34):3810-6. doi: 10.1200/JCO.2014.57.2909. Epub 2014 Oct 27. J Clin Oncol. 2014. PMID: 25349290 Free PMC article. Clinical Trial.
Does Hippocampal-Avoidance Whole-Brain Radiotherapy for Brain Metastases Meaningfully Change Current Practice?
Chamberlain MC. Chamberlain MC. J Clin Oncol. 2015 Jun 10;33(17):1985. doi: 10.1200/JCO.2014.60.4769. Epub 2015 Apr 20. J Clin Oncol. 2015. PMID: 25897152 No abstract available.